中国抗体主席梁瑞安博士将出席第44届摩根大通医疗健康大会并分享公司业务最新发展和未来展望

SINOMAB 中抗集团
Jan 09

中抗快报2026SinoMabNEWS—————————————(2026年1月9日---香港)中国抗体制药有限公司("中国抗体"或"公司",连同其附属公司统称"集团")(股份代号:03681.HK)执行董事、主席兼首席执行官梁瑞安博士将于美国当地时间1月12日受邀出席第44届摩根大通医疗健康大会(J.P. Morgan Healthcare Conference),并分享公司近期业务进展和未来...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10